Back to search

Switzerland· 67517003

Deferasirox Accord

A deferasirox product containing deferasiroxum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC V03AC03

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedDeferasirox AccordATCV03AC03REGISTER NO.67517003PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Deferasirox is registered in 18 of 19 countries.

Countries holding a registration under ATC V03AC03 (deferasirox), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 10 of them publish a price we can compare per daily dose

Deferasirox · ATC V03AC03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deferasirox costs, country by country.

Normalised to the WHO defined daily dose (0.98 g), the median price runs from $27.16 in France to $59.57 in Switzerland — a ×2.2 gap.

  • Switzerland: $59.57 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Deferasirox · price per daily dose (0.98 g)

USD · FX 28 Sept 2026

  • CH Switzerland$59.57
  • IT Italy$43.21
  • FR France$27.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
deferasiroxum
Manufacturer
—
Country
Switzerland (CH)
ATC code
V03AC03
ATC class
Deferasirox
Defined daily dose
0.98 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680675170036
    Blist 30 Stk
    CHF 272.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

616 interactions on record for deferasirox.

Graded by severity as the source publishes them — 205 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Deferasirox · interactions on record

616 records

  • 205 severe
  • 399 moderate
  • 12 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deferasirox in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deferasirox products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Deferasirox G.L., Deferasirox Ratiopharm
  • Belgium · Deferasirox Ab, Deferasirox Ab Ab
  • Bulgaria · Deferasirox Synthon, Ziadex
  • Cyprus · Deferasirox Msn, Issoferrol
  • Czechia · Deferasirox Auxpharma, Deferasirox Glenmark
  • Germany · Deferasi Puren, Deferasirox Abdi
  • Denmark · Deferasirox Deferasirox "jubilant", Deferasirox Glenmark
  • Spain · Deferasirox Abdi, Deferasirox Aurovitas
  • Finland · Deferasirox Glenmark, Deferasirox Stada
  • France · Deferasirox Arrow, Deferasirox Bgr
  • United Kingdom (Northern Ireland) · Deferasirox Abdi Farma, Deferasirox Amarox
  • Greece · Deferasirox Pharmathen, Deferasirox Rafarm
  • Croatia · Deferasiroks Pliva, Deferasiroks Umedica
  • Hungary · Deferasirox Msn, Deferasirox Pharmascience
  • Iceland · Deferasirox Accord, Deferasirox Medical Valley
  • Italy · Deferasirox Abdi, Deferasirox Aurobindo
  • Liechtenstein · Deferasirox Accord, Deferasirox Mylan
  • Latvia · Deferasirox Umedica
  • Malta · Deferasirox Pharos
  • Netherlands · Deferasirox Abdi, Deferasirox Amarox
  • Norway · Deferasirox Accord, Deferasirox Medical Valley
  • Poland · Deferasirox Msn, Exferana
  • Portugal · Deferasirox 180 Mg, Deferasirox 360 Mg
  • Romania · Deferasirox Msn Laboratories, Deferasirox Sanexcel
  • Sweden · Deferasirox Glenmark, Deferasirox Jubilant
  • Slovakia · Deferasirox, Deferasirox Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e40cb037-ef16-4a78-b2af-20b693b5680c
GET /v1/drugs/e40cb037-ef16-4a78-b2af-20b693b5680c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "deferasiroxum 180 mg",
  "valid_from": "2021-06-01",
  "limitations": "[{\"description\":\"Eine Vergütung erfolgt<br>\\n&nbsp;- als Erstlinientherapie zur Behandlung der chronischen Eisenüberladung auf Grund häufiger Transfusionen bei Patienten mit Beta-Thalassämia major.<br> \\n&nbsp;- für die Behandlung von weiteren chronischen, transfusionsbedingten Eisenüberladungen, wenn eine Deferoxamin-Therapie kontraindiziert oder unangemessen ist. <br>\\n&nbsp;- für die Behandlung der chronischen Eisenüberladung bei Patienten mit nicht transfusionsabhängigen Thalassämie-Syndromen im Alter von 10 Jahren und älter, wenn eine Deferoxamin-Therapie kontraindiziert oder unangemessen ist.<br>\\n<br>\\nTherapien, die vor der Einführung der angepassten Limitierung (1. Juni 2023) begonnen wurden, werden weiterhin vergütet, sofern es sich um eine Behandlung entsprechend der von Swissmedic zugelassenen Indikation handelt.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2023-06-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 180 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2021-06-01",
  "self_retention_pct": 10
}

See everything about deferasirox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.